Drug information for VANIQA
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CREAM; TOPICAL
13.9%
Prescription
(Reference Drug)
EFLORNITHINE HYDROCHLORIDE
Eflornithine
SKINMEDICA
21145
2007-09-13 Review
2007-09-13 Review
2007-09-13 Review
2007-09-13 Review
2003-07-08 Review
2000-07-27 Letter
2000-07-27 Label
Drug Adverse Effects information for VANIQA
Role code
Indications
Reaction
# Reports
C
DEPRESSION
DEEP VEIN THROMBOSIS
1
C
DEPRESSION
INJURY
1
C
DEPRESSION
MENTAL DISORDER
1
C
DEPRESSION
PAIN
1
C
DEPRESSION
PULMONARY EMBOLISM
1
C
PREMENSTRUAL SYNDROME
DEEP VEIN THROMBOSIS
3
C
PREMENSTRUAL SYNDROME
INJURY
3
C
PREMENSTRUAL SYNDROME
MENTAL DISORDER
3
C
PREMENSTRUAL SYNDROME
PAIN
3
C
PREMENSTRUAL SYNDROME
PULMONARY EMBOLISM
3
Ads by Google